Genetic evidence for an interferon-antagonistic function of Rift Valley fever virus nonstructural protein NSs

Journal of Virology

Volumn 75, Issue 3, 2001, Pages 1371-1377

  Bouloy, M ^a   Janzen, C ^a   Vialat, P ^a   Khun, H ^a   Pavlovic, J ^a   Huerre, M ^a   Haller, O ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON RECEPTOR; BETA INTERFERON; BETA INTERFERON RECEPTOR; GAMMA INTERFERON RECEPTOR; INTERFERON RECEPTOR; PHOSPHOPROTEIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CYTOKINE PRODUCTION; GENE; GENE MUTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RIFT VALLEY FEVER BUNYAVIRUS; VIRUS VIRULENCE;

ANIMALS; INTERFERON-ALPHA; INTERFERON-BETA; MICE; MICE, INBRED STRAINS; RECEPTORS, INTERFERON; RIFT VALLEY FEVER VIRUS; VIRAL NONSTRUCTURAL PROTEINS; VIRULENCE;

EID: 0035152344     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.3.1371-1377.2001     Document Type: Article

References (47)

1. Viral determinants of virulence for Rift Valley fever (RVF) in rats
2. The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-alpha
3. Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication
4. Rescue of a segmented negative-stranded RNA virus entirely from cloned complementary DNAs
5. Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development
6. The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase
7. JNK2 and IKKbeta are required for activating the innate response to viral infection
8. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems
9. Molecular biology of phleboviruses
10. Sequences and coding strategies of the S RNAs of Toscana and Rift Valley fever viruses compared to those of Punta Toro, Sicilian sandfly fever, and Uukuniemi viruses
11. Interferons: Cell signalling, immune modulation, antiviral response and virus countermeasures
12. Demonstration of yellow fever and dengue antigens in formalin-fixed paraffin-embedded human liver by immunohistochemical analysis
13. Genetically determined, interferon-dependent resistance to influenza virus in mice
14. Human MxA protein protects mice lacking a functional alpha/beta interferon system against La Crosse virus and other lethal viral infections
15. Induction of virus-inhibiting factor or interferon in mice by strains with different virulence of Rift Valley fever virus
16. A recombinant human interferon-alpha B/D hybrid with a broad host-range
17. Immune response in mice that lack the interferon-gamma receptor
18. When two strands are better than one: The mediators and modulators of the cellular responses to double-stranded RNA
19. The Rift Valley fever virus nonstructural protein NSs is phosphorylated at serine residues located in casein kinase consensus motifs in the carboxy-terminus
20. Products of the porcine group C rotavirus NSP3 gene bind specifically to double-stranded RNA and inhibit activation of the interferon-induced protein kinase PKR
21. Specific phenotypic restoration of an attenuated virus by knock-out of a host resistance gene
22. The L protein of Rift Valley fever virus can rescue viral ribonucleoproteins and transcribe synthetic genome-like RNA molecules
23. Rift Valley fever virus hepatitis light and electron microscopic studies in the mouse
24. The Rift Valley fever epizootic in Egypt 1977-78: Description of the epizootic and virological studies
25. Rift Valley fever
26. Prevention of Rift Valley fever in rhesus monkeys with interferon-alpha
27. Pathogenesis of Rift Valley fever in rhesus monkeys: Role of interferon response
28. Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment
29. Functional role of type I and type II interferons in antiviral defense
30. In situ analysis of proteolipid protein gene transcripts during persistent Theiler's virus infection
31. Pathogenesis of Rift Valley fever
32. Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator
33. An IκB homolog encoded by African swine fever virus provides a novel mechanism for down-regulation of proinflammatory cytokine responses in host macrophages
34. Analysis of the 3′ terminal sequence recognized by the Rift Valley fever virus transcription complex in its ambisense S segment
35. Inhibition of nuclear factor kappaB activation by a virus-encoded IkappaB-like protein
36. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity
37. Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine
38. Bunyaviridae: The viruses and their replication
39. Rift valley fever: The neurotropic adaption of the virus and the experimental use of this modified virus as a vaccine
40. How cells respond to interferons
41. Identification of mutations in the mRNA of a candidate vaccine strain of Rift Valley fever virus
42. Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein
43. The S segment of Rift valley fever Phlehovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice
44. Mapping of the mutations present in the genome of the Rift Valley fever virus attenuated MP12 strain and their putative role in attenuation
45. The carboxy-terminal acidic domain of Rift Valley fever virus NSs protein is essential for the formation of filamentous structures but not for the nuclear localization of the protein